Cambiar Investors LLC Has $40.23 Million Stock Holdings in CME Group Inc. $CME

Cambiar Investors LLC lowered its stake in shares of CME Group Inc. (NASDAQ:CME) by 7.6% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 148,900 shares of the financial services provider’s stock after selling 12,311 shares during the period. CME Group comprises about 1.8% of Cambiar Investors LLC’s investment portfolio, making the stock its 27th biggest holding. Cambiar Investors LLC’s holdings in CME Group were worth $40,231,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Caldwell Trust Co boosted its position in CME Group by 116.3% during the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 50 shares during the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA purchased a new stake in shares of CME Group during the 3rd quarter worth about $27,000. Financial Consulate Inc. acquired a new stake in shares of CME Group during the 3rd quarter valued at about $28,000. Sagard Holdings Management Inc. bought a new stake in shares of CME Group in the 2nd quarter valued at approximately $30,000. Finally, Corundum Trust Company INC acquired a new position in CME Group in the third quarter worth approximately $30,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director William R. Shepard bought 251 shares of the business’s stock in a transaction on Tuesday, December 30th. The shares were purchased at an average price of $278.37 per share, for a total transaction of $69,870.87. Following the purchase, the director owned 258,710 shares of the company’s stock, valued at approximately $72,017,102.70. The trade was a 0.10% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $263.53, for a total value of $263,530.00. Following the transaction, the director directly owned 1,091 shares of the company’s stock, valued at approximately $287,511.23. This trade represents a 47.82% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have issued reports on CME. JPMorgan Chase & Co. lifted their target price on shares of CME Group from $256.00 to $262.00 and gave the company an “underweight” rating in a research note on Thursday, January 22nd. Keefe, Bruyette & Woods lifted their price objective on shares of CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a research note on Monday, October 13th. Piper Sandler increased their target price on shares of CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. TD Cowen upgraded CME Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 14th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on CME Group from $310.00 to $318.00 and gave the stock a “buy” rating in a research note on Wednesday, December 17th. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, CME Group has an average rating of “Hold” and an average price target of $292.18.

CME Group Trading Up 0.2%

Shares of NASDAQ:CME opened at $284.48 on Wednesday. The firm has a market cap of $102.58 billion, a price-to-earnings ratio of 27.57, a PEG ratio of 3.20 and a beta of 0.27. CME Group Inc. has a 12 month low of $232.32 and a 12 month high of $290.79. The company’s fifty day simple moving average is $274.37 and its 200 day simple moving average is $272.05. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th were paid a $1.25 dividend. The ex-dividend date of this dividend was Friday, December 12th. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. CME Group’s dividend payout ratio (DPR) is currently 48.45%.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.